Ryan Lake - Jan 31, 2022 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Role
Chief Financial Officer
Signature
By: Ryan D. Lake
Stock symbol
SCTL
Transactions as of
Jan 31, 2022
Transactions value $
-$2,185
Form type
4
Date filed
2/2/2022, 03:30 PM
Previous filing
Jan 24, 2022
Next filing
Feb 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Tax liability -$2.19K -1.42K -0.26% $1.54 546K Jan 31, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units.